{"nctId":"NCT00304356","briefTitle":"Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection","startDateStruct":{"date":"2004-01"},"conditions":["Clostridium Enterocolitis","Pseudomembranous Colitis"],"count":22,"armGroups":[{"label":"active drug","type":"OTHER","interventionNames":["Drug: Nitazoxanide"]}],"interventions":[{"name":"Nitazoxanide","otherNames":["alinia"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient must be \\> 18 years of age\n* Clinical diagnosis of C. difficile associated disease, based on the new onset of diarrhea, abdominal discomfort, or otherwise unexplained fever or leukocytosis\n* Diagnosis of C. difficile colitis proven by positive assay for C. difficile toxin in feces\n* Disease has been treated, and the symptoms failed to respond to treatment with metronidazole or vancomycin, or symptoms promptly relapsed after completing a course of therapy with either of these drugs\n* Able to take oral medication\n\nExclusion Criteria:\n\n* Patients with other recognized causes of diarrhea or colitis\n* Women of child bearing age who are pregnant, breast feeding, or not using birth control\n* Patients taking coumadin, phenytoin, celecoxib, or losartan\n* Patients with renal insufficiency (BUN or creatinine \\>2 times baseline)\n* Serious systemic disorder incompatible with the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Nitazoxanide","description":"stopping of diarrhea","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":27},"commonTop":[]}}}